Clinical research progress on BRAF V600E-mutant advanced colorectal cancer. 2023

Chuanxiu Zeng, and Mengchao Wang, and Shuqi Xie, and Na Wang, and Zhen Wang, and Dan Yi, and Fanming Kong, and Liwei Chen
Oncology Department, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.

Colorectal cancer is one of the malignant tumors that pose a serious threat to human health. A particularly bad prognosis might be expected for colorectal tumors with the unique molecular subtype BRAF V600E mutation. With the development of precision therapy, the advent of molecularly targeted therapies and immune checkpoint inhibitors has improved the outcome of intermediate to advanced colorectal cancer. However, the duration of drug benefit is usually short, and overall survival and progression-free survival remain suboptimal. Therefore, investigators are exploring more rational, safe, and effective drug combination regimens through clinical trials to provide longer survival for patients with such genetic mutations with metastatic colorectal cancer (mCRC). This article reviews the progress of clinical research on molecularly targeted drugs, immune checkpoint inhibitors, first-line chemotherapeutic agents, and different combination therapy regimens (including different targeted drug combinations, immune combination targeting, and chemotherapy combination targeting) for colorectal cancer patients with BRAF V600E mutation, which provides a reference for further in-depth clinical exploration of the treatment of colorectal cancer patients with BRAF V600E mutation.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000082082 Immune Checkpoint Inhibitors Drugs that block negative regulator IMMUNE CHECKPOINT proteins (e.g., PD-1 RECEPTOR and CTLA-4 ANTIGEN) thereby increasing suppressed immune activation in immunotherapies. CTLA-4 Inhibitor,CTLA-4 Inhibitors,Cytotoxic T-Lymphocyte-Associated Protein 4 Inhibitor,Cytotoxic T-Lymphocyte-Associated Protein 4 Inhibitors,Immune Checkpoint Blockade,Immune Checkpoint Blockers,Immune Checkpoint Inhibition,Immune Checkpoint Inhibitor,PD-1 Inhibitor,PD-1 Inhibitors,PD-1-PD-L1 Blockade,PD-L1 Inhibitor,PD-L1 Inhibitors,Programmed Cell Death Protein 1 Inhibitor,Programmed Cell Death Protein 1 Inhibitors,Programmed Death-Ligand 1 Inhibitors,Blockade, PD-1-PD-L1,CTLA 4 Inhibitor,CTLA 4 Inhibitors,Checkpoint Blockade, Immune,Checkpoint Blockers, Immune,Checkpoint Inhibition, Immune,Checkpoint Inhibitor, Immune,Checkpoint Inhibitors, Immune,Cytotoxic T Lymphocyte Associated Protein 4 Inhibitor,Cytotoxic T Lymphocyte Associated Protein 4 Inhibitors,Inhibitor, PD-1,PD 1 Inhibitor,PD 1 Inhibitors,PD 1 PD L1 Blockade,PD L1 Inhibitor,PD L1 Inhibitors,Programmed Death Ligand 1 Inhibitors
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal
D048493 Proto-Oncogene Proteins B-raf A raf kinase subclass found at high levels in neuronal tissue. The B-raf Kinases are MAP kinase kinase kinases that have specificity for MAP KINASE KINASE 1 and MAP KINASE KINASE 2. B-raf Kinase,BRAF Kinase,B-raf Kinases,BRAF Kinases,Proto-Oncogene Protein B-raf,B raf Kinase,B raf Kinases,B-raf, Proto-Oncogene Protein,B-raf, Proto-Oncogene Proteins,Kinase, B-raf,Kinase, BRAF,Protein B-raf, Proto-Oncogene,Proteins B-raf, Proto-Oncogene,Proto Oncogene Protein B raf,Proto Oncogene Proteins B raf

Related Publications

Chuanxiu Zeng, and Mengchao Wang, and Shuqi Xie, and Na Wang, and Zhen Wang, and Dan Yi, and Fanming Kong, and Liwei Chen
January 2017, Clinical cancer research : an official journal of the American Association for Cancer Research,
Chuanxiu Zeng, and Mengchao Wang, and Shuqi Xie, and Na Wang, and Zhen Wang, and Dan Yi, and Fanming Kong, and Liwei Chen
September 2020, Bulletin du cancer,
Chuanxiu Zeng, and Mengchao Wang, and Shuqi Xie, and Na Wang, and Zhen Wang, and Dan Yi, and Fanming Kong, and Liwei Chen
October 2021, Expert opinion on biological therapy,
Chuanxiu Zeng, and Mengchao Wang, and Shuqi Xie, and Na Wang, and Zhen Wang, and Dan Yi, and Fanming Kong, and Liwei Chen
January 2023, Expert review of anticancer therapy,
Chuanxiu Zeng, and Mengchao Wang, and Shuqi Xie, and Na Wang, and Zhen Wang, and Dan Yi, and Fanming Kong, and Liwei Chen
June 2017, Cancer discovery,
Chuanxiu Zeng, and Mengchao Wang, and Shuqi Xie, and Na Wang, and Zhen Wang, and Dan Yi, and Fanming Kong, and Liwei Chen
January 2022, Therapeutic advances in medical oncology,
Chuanxiu Zeng, and Mengchao Wang, and Shuqi Xie, and Na Wang, and Zhen Wang, and Dan Yi, and Fanming Kong, and Liwei Chen
May 2018, Annals of oncology : official journal of the European Society for Medical Oncology,
Chuanxiu Zeng, and Mengchao Wang, and Shuqi Xie, and Na Wang, and Zhen Wang, and Dan Yi, and Fanming Kong, and Liwei Chen
January 2018, Case reports in surgery,
Chuanxiu Zeng, and Mengchao Wang, and Shuqi Xie, and Na Wang, and Zhen Wang, and Dan Yi, and Fanming Kong, and Liwei Chen
February 2016, Melanoma research,
Chuanxiu Zeng, and Mengchao Wang, and Shuqi Xie, and Na Wang, and Zhen Wang, and Dan Yi, and Fanming Kong, and Liwei Chen
April 2023, Cancer letters,
Copied contents to your clipboard!